Can-Fite BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	6.45	4.83	4.28	2.98	4.39	8.27
Short-Term Investments	0	3.06	4.64	5.01	14.75	0.08
Cash & Short-Term Investments	6.46	7.89	8.92	7.99	19.14	8.34
Cash Growth	36.55%	-11.60%	11.71%	-58.27%	129.40%	202.17%
Other Current Assets	1.17	1.1	0.99	1.17	0.93	1.06
Total Current Assets	7.62	8.98	9.91	9.16	20.07	9.4
Net Property, Plant & Equipment	0.1	0.14	0.08	0.13	0.19	0.12
Total Assets	7.72	9.12	9.99	9.28	20.25	9.52
Accounts Payable	1.15	0.62	0.43	0.9	0.95	0.56
Accrued Expenses	0.51	0.98	0.94	0.78	0.91	0.33
Current Portion of Leases	0.06	0.05	0.03	0.05	0.05	0.04
Unearned Revenue	0.41	0.41	0.62	0.78	0.82	0.33
Total Current Liabilities	2.12	2.05	2.02	2.5	2.73	1.27
Long-Term Leases	0.03	0.05	0.01	0.01	0.07	0.02
Other Long-Term Liabilities	1.38	1.58	1.71	2.3	3.07	2.16
Total Long-Term Liabilities	1.42	1.63	1.73	2.31	3.14	2.18
Total Liabilities	3.54	3.68	3.75	4.81	5.87	3.45
Common Stock	-	-	-	-	-	33.04
Additional Paid-in Capital	174.29	170.67	163.6	154.19	153.93	97.38
Accumulated Other Comprehensive Income	1.13	1.13	1.13	1.13	1.13	1.13
Retained Earnings	-171.24	-166.36	-158.48	-150.85	-140.67	-125.47
Shareholders' Equity	4.18	5.44	6.24	4.47	14.38	6.07
Total Liabilities & Equity	7.72	9.12	9.99	9.28	20.25	9.52
Total Debt	0.09	0.1	0.04	0.06	0.12	0.07
Net Cash (Debt)	6.37	7.78	8.88	7.93	19.02	8.28
Net Cash Growth	-18.21%	-12.37%	12.08%	-58.32%	129.76%	208.12%
Net Cash Per Share	1928.29	3219.18	6253.30	8743.53	30942.20	20781.71
Book Value	4.18	5.44	6.24	4.47	14.38	6.07
Book Value Per Share	1267.35	2248.42	4395.33	4933.89	23403.14	15252.31
Tangible Book Value	4.18	5.44	6.24	4.47	14.38	6.07
Tangible Book Value Per Share	1267.35	2248.42	4395.33	4933.89	23403.14	15252.31

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q